(Q38071935)

28 August 2017

1 reference

title

Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease (English)

1 reference

non-alcoholic fatty liver

28 August 2017

main subject

1 reference

metabolic dysfunction–associated steatotic liver disease

inferred from title

1 reference

Nikolaos K Gatselis

1

1 reference

28 August 2017

George Ntaios

series ordinal

2

1 reference

28 August 2017

Konstantinos Makaritsis

series ordinal

3

1 reference

28 August 2017

George N Dalekos

series ordinal

4

1 reference

28 August 2017

publication date

5 January 2013

1 reference

Clinical and Experimental Medicine

28 August 2017

published in

1 reference

28 August 2017

volume

14

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

121-131

1 reference

https://scigraph.springernature.com/pub.10.1007/s10238-012-0227-0

28 August 2017

exact match

0 references

cites work

AGA technical review on nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Recent concepts in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adipokines: the missing link between insulin resistance and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adipocytokines and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Systemic fate of the adipocyte-derived factor adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Post-translational modifications of adiponectin: mechanisms and functional implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adiponectin in insulin resistance: lessons from translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Changes of adiponectin oligomer composition by moderate weight reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

High-molecular weight adiponectin isoforms increase after biliopancreatic diversion in obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adiponectin and adiponectin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

PPARalpha: energy combustion, hypolipidemia, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARalpha and SREBP-1c signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adiponectin differentially regulates cytokines in porcine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Both adiponectin and interleukin-10 inhibit LPS-induced activation of the NF-κB pathway in 3T3-L1 adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

21 January 2018

From fat to inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Cytokines in alcoholic and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adiponectin, a Fat Cell Product, Influences the Earliest Lymphocyte Precursors in Bone Marrow Cultures by Activation of the Cyclooxygenase-Prostaglandin Pathway in Stromal Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

The role of adipokines in liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adiponectin induces the transforming growth factor decoy receptor BAMBI in human hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Steatosis: co-factor in other liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Review article: hepatitis C virus-associated steatosis--pathogenic mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Histopathology of Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Fibrosis is associated with adiponectin resistance in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Total and high molecular weight adiponectin and hepatocellular carcinoma with HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Pathologic assessment of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adiponectin as an independent predictor of the presence and degree of hepatic steatosis in the Dallas Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Inverse association between serum adiponectin level and transaminase activities in Japanese male workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Plasma adiponectin is decreased in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adiponectin and its receptors in rodent models of fatty liver disease and liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Study of adiponectin in chronic liver disease and cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Lifestyle modification increases circulating adiponectin concentrations but does not change vaspin concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Weight loss increased serum adiponectin but decreased lipid levels in obese subjects whose body mass index was lower than 30 kg/m².

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adiponectin changes in relation to the macronutrient composition of a weight-loss diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

PPARgamma-independent increase in glucose uptake and adiponectin abundance in fat cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Impact of trandolapril therapy and its combination with a calcium channel blocker on plasma adiponectin levels in patients with type 2 diabetes and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Potential utility of telmisartan, an angiotensin II type 1 receptor blocker with peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-modulating activity for the treatment of cardiometabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0227-0

Delayed liver regeneration after partial hepatectomy in adiponectin knockout mice

21 January 2018

1 reference

12 December 2020

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

1 reference

12 December 2020

Prevalence of and risk factors for hepatic steatosis in Northern Italy

1 reference

12 December 2020

Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model

1 reference

12 December 2020

Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients

1 reference

12 December 2020

Telmisartan increases adiponectin levels: a meta-analysis and meta-regression of randomized head-to-head trials

1 reference

12 December 2020

Insulin resistance: cause or consequence of nonalcoholic steatohepatitis?

1 reference

12 December 2020

Inhibition by AICA Riboside of Gluconeogenesis in Isolated Rat Hepatocytes

1 reference

12 December 2020

Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease

1 reference

12 December 2020

The association between adipocytokines and biomarkers for nonalcoholic fatty liver disease-induced liver injury: a study in the general population

1 reference

12 December 2020

NASH predicts plasma inflammatory biomarkers independently of visceral fat in men

1 reference

12 December 2020

Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages

1 reference

12 December 2020

The significance of serum levels of adiponectin, leptin, and hyaluronic acid in hepatocellular carcinoma of cirrhotic and noncirrhotic patients

1 reference

12 December 2020

Adipokines and cytokines in non-alcoholic fatty liver disease

1 reference

12 December 2020

High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo

1 reference

12 December 2020

Race-ethnic differences in adipokine levels: the Study of Women's Health Across the Nation (SWAN).

1 reference

12 December 2020

Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

1 reference

12 December 2020

Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies

1 reference

12 December 2020

Alterations of leptin during IFN-alpha therapy in patients with chronic viral hepatitis

1 reference

12 December 2020

Changes in adipocytokines and insulin sensitivity during and after antiviral therapy for hepatitis C genotype 4.

1 reference

12 December 2020

Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis

1 reference

12 December 2020

Molecular mediators of hepatic steatosis and liver injury

1 reference

12 December 2020

Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease

1 reference

12 December 2020

Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH)

1 reference

12 December 2020

10.1007/S10238-012-0227-0

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1034851897

0 references

1 reference